WEHI Special ID2 Seminar hosted by Dr Eva Hesping
 

Professor Sally-Ann Poulsen

Deputy Director – Griffith Institute for Drug Discovery; Director – Compounds Australia, Griffith University

Development of novel chemical probes to visualise parasite proliferation and putting a spotlight on applying native mass spectrometry in biomedical research

 

Davis Auditorium

Join via TEAMS

Including Q&A session

Sally-Ann Poulsen is Professor, Principal Research Leader, and Deputy Director at Griffith Institute for Drug Discovery (GRIDD), Griffith University, Brisbane, Australia. Her research is defined by the application of chemistry expertise to address complex questions across biology. Working with collaborators in Australia and internationally, both from academia and industry, she leads projects to develop new chemical probes to study pathogens, develop improved chemical synthesis of nucleotides/DNA and RNA, and apply native mass spectrometry to advance biomedical research discoveries. Sally-Ann was recipient of the $1M 2023 Ramaciotti Biomedical Research Award to establish first-in-Australia technology and the ‘Ramaciotti National Native Mass Spectrometry Platform for Health Discoveries’. She contributes broadly across her discipline, including as Director of Compounds Australia, a flagship national compound management and logistics facility that a is part of the National Collaborative Research Infrastructure Strategy (NCRIS) Therapeutic Innovation Australia small molecules platform. Sally-Ann was appointed a Fellow, Royal Australian Chemical Institute (RACI) in 2017 and a Fellow, Royal Society of Chemistry (RSC) in 2023. She was Chair of the RACI Medicinal Chemistry and Chemical Biology Division 2021-2023′.

All welcome!